Sign in

CIK 0001953926 · <br>Emerging growth company

Zenas BioPharma, Inc.

Sign in to watch
Ticker
ZBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
857-271-2954
Business address
852 WINTER STREET, SUITE 250, WALTHAM, MA, 02451
Former names
Zenas BioPharma (Cayman) Ltd
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-09-20 MOULDER LEON O JR Chief Executive Officer Purchase +2,633 $18.97 $50K 1,672,039
2024-09-19 MOULDER LEON O JR Chief Executive Officer Purchase +5,000 $17.89 $89K 1,667,039
2024-09-18 MOULDER LEON O JR Chief Executive Officer Purchase +10,000 $17.91 $179K 1,662,039
2024-09-16 Enavate Sciences GP, LLC 10% owner Conversion +2,879,006 2,879,006
2024-09-16 Enavate Sciences GP, LLC 10% owner Purchase +882,353 $17.00 $15.0M 3,761,359
2024-09-16 Enavate Sciences GP, LLC 10% owner Conversion · Series B Preferred Stock −10,474,889 0
2024-09-16 Enavate Sciences GP, LLC 10% owner Conversion · Series C Preferred Stock −14,523,821 0
2024-09-16 Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% owner Conversion +180,635 180,635
2024-09-16 Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% owner Conversion +420,271 600,906
2024-09-16 Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% owner Conversion +200,718 801,624
2024-09-16 Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% owner Conversion · Series A Convertible Preferred Stock −1,568,480 0
2024-09-16 Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% owner Conversion · Series B Convertible Preferred Stock −3,649,263 0
2024-09-16 Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% owner Conversion · Series C Convertible Preferred Stock −1,742,858 0
2024-09-16 Fairmount Funds Management LLC Director Conversion +41,130 329,045
2024-09-16 Fairmount Funds Management LLC Director Conversion +252,890 581,935
2024-09-16 Fairmount Funds Management LLC Director Conversion +709,794 1,291,729
2024-09-16 Fairmount Funds Management LLC Director Conversion +301,077 1,592,806
2024-09-16 Fairmount Funds Management LLC Director Purchase +300,000 $17.00 $5.1M 1,892,806
2024-09-16 Fairmount Funds Management LLC Director Conversion · Series Seed Convertible Preferred Stock −357,143 0
2024-09-16 Fairmount Funds Management LLC Director Conversion · Series A Convertible Preferred Stock −2,195,871 0

Page 4 of 8 · 145 trades